CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Aura Medsystems

Aura Medsystems is a Duxbury, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CMC ICOS Biologics Inc.

CMC ICOS Biologics Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Bothell, WA. To find more information about CMC ICOS Biologics Inc., please visit www.cmcbio.com

Electromed Co

Electromed Co is a City Of Industry, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Certified Medical Inc

Certified Medical Inc is a Round Rock, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medico Mart Inc

Medico Mart Inc is a Waukesha, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.